Advanced or Recurrent Endometrial Cancer Clinical Trial
0 意见
• 07/09/23
0
0
嵌入
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论